1. Craig, CM et al. “efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycemia”. Diabetes Obes Metab. 2017; 1-10. (click to view PDF)
  2. Craig, C. et al. “Critical role for GLP-1 in symptomatic post-bariatric hypoglycemia”, Diabetologia, 2016. (click to view PDF)
  3. Angrisani, L. et al. “Bariatric Surgery Worldwide 2013”, Obes Surg, 2015; 1(click to view PDF)
  4. Goldfine, A. et al. “The rollercoaster of post-bariatric hypoglycemia”, Lancet, 2016; 4:94. (click to view PDF)
  5. Patti, M. et al. “Hypoglycemia After Gastric Bypass: The Dark Side of GLP-1”, Gastroenterology, 2014; 146(3): 605. (click to view PDF)
  6. Salehi, M. et al. “Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass”, Gastroenterology. 2014; 146: 669-680. (click to view PDF)
  7. Singh, E. et al. “Hypoglycemia After Gastric Bypass Surgery”, Diabetes Spectrum. 2012; 25: 217-221. (click to view PDF)


EventPresentation DetailsTypePDF
ADA Meeting,
March 2019
Baltimore, MD
28-Day Dosing with AvexitideImproves HyperinsulinemicHypoglycemia in Patients with Severe, Refractory Post-Bariatric Hypoglycemia: The Prevent StudyPresentationPDF Icon
ADA Meeting,
June 2017
San Diego, CA
Repeat subcutaneous dosing of Exendin 9-39 reduces hyperinsulinemic hypoglycemia and neuroglycopenic symptoms in patients with post-bariatric hypoglycemiaPosterPDF Icon
PBH KOL/Analyst Event,
December 2016
New York, NY
Developing a Treatment for Post-Bariatric HypoglycemiaOral PresentationPDF Icon
ADA, June 2016
New Orleans, LA
Craig, C. et al – “Subcutaneous exendin 9-39 effectively treats post-bariatric hypoglycemia”Oral PresentationPDF Icon

Post-bariatric Hypoglycemia